[1]石 健,张 骋.过敏性紫癜病因及发病机制的研究[J].医学信息,2022,35(04):49-52.[doi:10.3969/j.issn.1006-1959.2022.04.013]
 SHI Jian,ZHANG Cheng.Study on Etiology and Pathogenesis of Henoch-Sch?觟nlein Purpura[J].Medical Information,2022,35(04):49-52.[doi:10.3969/j.issn.1006-1959.2022.04.013]
点击复制

过敏性紫癜病因及发病机制的研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年04期
页码:
49-52
栏目:
综述
出版日期:
2022-02-15

文章信息/Info

Title:
Study on Etiology and Pathogenesis of Henoch-Sch?觟nlein Purpura
文章编号:
1006-1959(2022)04-0049-04
作者:
石 健张 骋
日照市人民医院皮肤性病科,山东 日照 276800
Author(s):
SHI JianZHANG Cheng
Department of Dermatology,Rizhao People’s Hospital,Rizhao 276800,Shandong,China
关键词:
过敏性紫癜微生物菌群免疫细胞
Keywords:
Henoch-Sch?觟nlein purpuraMicrobial floraImmune cells
分类号:
R725.5
DOI:
10.3969/j.issn.1006-1959.2022.04.013
文献标志码:
A
摘要:
过敏性紫癜又称亨诺克-舒恩莱因紫癜或IgA免疫复合物血管炎。该病是一类以可触及性非血小板减少性紫癜、关节炎、胃肠道累及和肾脏累及为特征的白细胞碎裂性血管炎。过敏性紫癜的病因与感染、药物反应、遗传等因素密切相关。目前,临床关于过敏性紫癜发病机制的研究主要集中在免疫细胞、炎症因子、非编码RNA以及微生物菌群等方面。本文就过敏性紫癜的病因、发病机制进行综述,以期为该病的临床治疗提供参考。
Abstract:
Anaphylactoid purpura,also called Henoch-Sch?觟nlein purpura or IgA Vasculitis,is a kind of leukocyte rupture vasculitis characterized by palpable and non-thrombocytopenic purpura,arthritis, abdominal and renal involvement. It has been reported that the etiology of HSP is closely related to infection, drug reaction, genetics and other factors. Currently, the relevant studies on the pathogenesis of Henoch-Sch?觟nlein purpura have emerged in an endless stream, mainly focusing on immune cells, inflammatory factors, non-coding RNA and microorganisms. This article reviews the etiology and pathogenesis of Henoch-Sch?觟nlein purpura, in order to provide reference for clinical treatment of the disease.

参考文献/References:

[1]Sharif K,Shoenfeld Y.All Magic Comes with a Price:A Case of Henoch-Sch?觟nlein Purpura Post-influenza Vaccination[J].Isr Med Assoc J,2020,22(10):648-649.[2]Belkaid S,Berger M,Nouvier M,et al.A case of Schonlein-Henoch purpura induced by immune checkpoint inhibitor in a patient with metastatic melanoma[J].Eur J Cancer,2020(139):169-172.[3]Chelli C,Loget J,Vanhaecke C,et al.Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis[J].Acta Derm Venereol,2020,100(6):adv00077.[4]Omarini C,Molinaro E,Barbolini M,et al.Henoch-sch?觟nlein Purpura (HSP) in a patient on Abemaciclib[J].Breast,2020(52):132-133.[5]Condamina M,Diaz E,Jamart C,et al.Severe Attack of Henoch-Sch?觟nlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s Disease[J].J Crohns Colitis,2020,14(4):538-542.[6]Mazumder S,Ma M,Champigny M,et al.A Case of Adult-onset Henoch-Sch?觟nlein Purpura Triggered by Fire Ants[J].Cureus,2020,12(3):e7341.[7]Jin Y,Xie Q,Li N,et al.Exploration of susceptible genes associated with Henoch-Sch?觟nlein purpura by whole exome sequencing[J].Adv Clin Exp Med,2019,28(9):1199-1207.[8]Cakici EK,Kurt Sükür ED,Ozlü SG,et al.MEFV gene mutations in children with Henoch-Sch?觟nlein purpura and their correlations-do mutations matter?[J].Clin Rheumatol,2019,38(7):1947-1952.[9]Philippe E,Barnier A,Menguy J,et al.Henoch-Sch?觟nlein Purpura Associated with Lung Cancer:When Paraneoplastic Manifestations Impede Oncological Management[J].Case Reports Immunol,2021(2021):8847017.[10]Chen H,Li C,Ye W,et al.Henoch-Sch?觟nlein purpura in a patient with oesophageal cancer:A case report[J].Medicine (Baltimore),2020,99(49):e23492.[11]Omma A,Enecik ME,Ozbalkan Z,et al.Rectal Adenocarcinoma As An Uncommon Cause of Immunoglobulin A Vasculitis (Henoch-Sch?觟nlein Purpura)[J].Arch Rheumatol,2017,32(2):158-161.[12]Li B,Ren Q,Ling J,et al.Clinical relevance of neutrophil-to-lymphocyte ratio and mean platelet volume in pediatric Henoch-Schonlein Purpura:a meta-analysis[J].Bioengineered,2021,12(1):286-295.[13]常红,林毅,雷珂,等.SOCS低甲基化在儿童过敏性紫癜Th17/Treg细胞失衡中的作用研究[J].中国当代儿科杂志,2019,21(1):38-44.[14]Imai T,Nishiyama K,Ueki K,et al.Involvement of activated cytotoxic T lymphocytes and natural killer cells in Henoch-Sch?觟nlein purpura nephritis[J].Clin Transl Immunology,2020,9(11):e1212.[15]Chai W,Wang X,Wang W,et al.Decreased glycolysis induced dysfunction of NK cells in Henoch-Schonlein purpura patients[J].BMC Immunol,2020,21(1):53.[16]Luo S,Liang G,Zhang P,et al.Aberrant histone modifications in peripheral blood mononuclear cells from patients with Henoch-Sch?觟nlein purpura[J].Clin Immunol,2013,146(3):165-175.[17]王彬,邵宽芙蓉,董晨.滤泡辅助性T细胞及半乳糖缺乏的IgA1在儿童过敏性紫癜中的表达及意义[J].中国当代儿科杂志,2020,22(5):473-477.[18]Liu Q,Yang Y,Ge S,et al.Serum level of advanced oxidation protein products (AOPPs) in patients with Henoch-Schonlein purpura and its relationship with aberrant glycosylation of IgA1 and Cosmc mRNA expression[J].Int J Dermatol,2019,58(9):1092-1097.[19]马腾腾.儿童过敏性紫癜急性期血浆内皮微粒表达水平及意义[D].保定:河北大学,2019.[20]张丽,郝现伟,刘欣跃,等.血清正五聚蛋白3、基质金属蛋白酶-9、白介素-17及C反应蛋白在小儿过敏性紫癜诊断中的临床意义[J].中国临床医生杂志,2016,44(8):93-95.[21]Li J,Chen M,Wang J,et al.MicroRNA profiling in Chinese children with Henoch-Schonlein purpura and association between selected microRNAs and inflammatory biomarkers[J].Acta Paediatr,2021,110(7):2221-2229. [22]Cheng S,Zhu CH,Zhang AH,et al.MiR-29b expression is altered in crescent formation of HSPN and accelerates Ang Ⅱ-induced mesangial cell activation[J].World J Pediatr,2020,16(2):201-212.[23]Yang B,Tan X,Xiong X,et al.Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Sch?觟nlein purpura nephritis[J].Immunol Res,2017,65(3):592-604. [24]Yu SF,Feng WY,Chai SQ,et al.Down-Regulation of miR-218-5p Promotes Apoptosis of Human Umbilical Vein Endothelial Cells Through Regulating High-Mobility Group Box-1 in Henoch-Schonlein Purpura[J].Am J Med Sci,2018,356(1):64-71.[25]Pang S,Lv J,Wang S,et al.Differential expression of long non-coding RNA and mRNA in children with Henoch-Sch?觟nlein purpura nephritis[J].Exp Ther Med,2019,17(1):621-632.[26]Wang X,Zhang L,Wang Y,et al.Gut microbiota dysbiosis is associated with Henoch-Sch?觟nlein Purpura in children[J].Int Immunopharmacol,2018(58):1-8.[27]Wang JK,Yan B,Zhao JM,et al.Effect of gut microbiota from Henoch-Sch?觟nlein Purpura patients on acid-sensitive ion channel 3 expression and intestinal motility in germ-free rats[J].BMC Pediatr,2021,21(1):536. [28]Zhang Y,Xia G,Nie X,et al.Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes[J].Front Cell Infect Microbiol,2021(11):641997.[29]Chen B,Wang J,Wang Y,et al.Oral microbiota dysbiosis and its association with Henoch-Sch?觟nlein Purpura in children[J].Int Immunopharmacol,2018(65):295-302.[30]Gao R,Niu X,Zhu L,et al.iTRAQ quantitative proteomic analysis differentially expressed proteins and signal pathways in Henoch-Sch?觟nlein purpura nephritis[J].Am J Transl Res,2020,12(12):7908-7922.[31]Fang X,Wu H,Lu M,et al.Urinary proteomics of Henoch-Sch?觟nlein purpura nephritis in children using liquid chromatography-tandem mass spectrometry[J].Clin Proteomics,2020(17):10.[32]Fang X,Lu M,Xia Z,et al.Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Sch?觟nlein purpura nephritis[J].J Proteomics,2021(230):103979.[33]Omma A,Colak S,Can Sandikci S,et al.Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Sch?觟nlein purpura)[J].Int J Rheum Dis,2019,22(10):1920-1925.[34]Jiang MY,Li W,Xu XP,et al.Role of p300 in the pathogenesis of Henoch-Schonlein purpura nephritis and as a new target of glucocorticoid therapy in mice[J].Chin Med J (Engl),2019,132(16):1942-1950.

相似文献/References:

[1]谢桃李,孙礼宾.血清25-羟维生素D在过敏性紫癜中的研究[J].医学信息,2019,32(09):116.[doi:10.3969/j.issn.1006-1959.2019.09.038]
 XIE Tao-li,SUN Li-bin.Study on Serum 25-hydroxyvitamin D in Henoch-Sch?觟nlein Purpura[J].Medical Information,2019,32(04):116.[doi:10.3969/j.issn.1006-1959.2019.09.038]
[2]关 楠.平凉市儿童过敏性紫癜相关环境因素调查研究[J].医学信息,2019,32(11):144.[doi:10.3969/j.issn.1006-1959.2019.11.042]
 GUAN Nan.Investigation on Environmental Factors Related to Children's Henoch-Schonlein Purpura in Pingliang City[J].Medical Information,2019,32(04):144.[doi:10.3969/j.issn.1006-1959.2019.11.042]
[3]冯晓阳,陆海涛,王 薇,等.溶菌酶肠溶片治疗过敏性紫癜的临床疗效[J].医学信息,2019,32(19):153.[doi:10.3969/j.issn.1006-1959.2019.19.050]
 FENG Xiao-yang,LU Hai-tao,WANG Wei,et al.Clinical Efficacy of Lysozyme Enteric-coated Tablets in the Treatment of Henoch-Schonlein Purpura[J].Medical Information,2019,32(04):153.[doi:10.3969/j.issn.1006-1959.2019.19.050]
[4]张 健.孟鲁司特钠联合氯雷他定治疗小儿过敏性紫癜的疗效及对炎性因子、免疫球蛋白水平的影响[J].医学信息,2022,35(15):107.[doi:10.3969/j.issn.1006-1959.2022.15.024]
 ZHANG Jian.Effect of Montelukast Sodium Combined with Loratadine in the Treatment of Anaphylactoid Purpura in Children and its Effect on Inflammatory Factors and Immunoglobulin Levels[J].Medical Information,2022,35(04):107.[doi:10.3969/j.issn.1006-1959.2022.15.024]
[5]竺 琴,罗 军,向金波.儿童紫癜性肾炎的免疫机制研究[J].医学信息,2020,33(17):50.[doi:10.3969/j.issn.1006-1959.2020.17.015]
 ZHU Qin,LUO Jun,XIANG Jin-bo.Study on the Immune Mechanism of Children’s Purpuric Nephritis[J].Medical Information,2020,33(04):50.[doi:10.3969/j.issn.1006-1959.2020.17.015]
[6]潘 馨,刘佳奕,王 艳,等.幽门螺杆菌感染与儿童过敏性紫癜相关性的Meta分析[J].医学信息,2023,36(02):92.[doi:10.3969/j.issn.1006-1959.2023.02.018]
 PAN Xin,LIU Jia-yi,WANG Yan,et al.Meta-analysis of the Correlation Between Helicobacter Pylori Infection and Henoch-Sch?nlein Purpura in Children[J].Medical Information,2023,36(04):92.[doi:10.3969/j.issn.1006-1959.2023.02.018]
[7]汪晶晶,孙礼宾.NLR、PLR与LMR在儿童过敏性紫癜肾损害中的相关性[J].医学信息,2022,35(05):111.[doi:10.3969/j.issn.1006-1959.2022.05.028]
 WANG Jing-jing,SUN Li-bin.Correlation of NLR, PLR and LMR in Renal Damage of Children with Henoch-Schonlein Purpura[J].Medical Information,2022,35(04):111.[doi:10.3969/j.issn.1006-1959.2022.05.028]
[8]罗添尹,刘岚菁,孙香娟.过敏性紫癜国际研究热点的文献计量分析[J].医学信息,2024,37(08):35.[doi:10.3969/j.issn.1006-1959.2024.08.006]
 LUO Tian-yin,LIU Lan-jing,SUN Xiang-juan.Bibliometric Analysis of International Research Hotspots of Anaphylactoid Purpura[J].Medical Information,2024,37(04):35.[doi:10.3969/j.issn.1006-1959.2024.08.006]

更新日期/Last Update: 1900-01-01